GO Therapeutics appoints Dr. Robert J. Wills to Board of Directors
04 oct. 2017 07h30 HE
|
GO Therapeutics
CAMBRIDGE, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics, a company exploiting new advances in glycoproteomics to develop novel, multimodal first-in-class cancer therapeutics against...
Antibody Drug Market Expected to Gain $30 Billion Through 2022
03 oct. 2017 14h30 HE
|
BCC Research
WELLESLEY, Mass. , Oct. 03, 2017 (GLOBE NEWSWIRE) -- An increase in research and development, burgeoning industry competition and evolving technologies are steering the antibody drug market into a...
Salubris Pharmaceuticals Invests $5 Million in GO Therapeutics
25 sept. 2017 12h06 HE
|
GO Therapeutics
CAMBRIDGE, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics today announced that Salubris Pharmaceutical Limited has made a $5M investment in GO Therapeutics, a Cambridge, MA-based company...
Market for Antibody Drug Conjugates to Reach $4.2B by 2021
10 août 2017 05h00 HE
|
BCC Research
WELLESLEY, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Technological advancements, the rising incidence of cancer, and an increasing demand for biologic therapies are driving the market for...